Brand | Abnova |
Product type | Primary antibodies |
Reactivity | Human,Mouse,Rat |
Host species | Goat |
Applications | ELISA,WB-Ce |
Brand: | Abnova |
Reference: | PAB6709 |
Product name: | AKT3 polyclonal antibody |
Product description: | Goat polyclonal antibody raised against synthetic peptide of AKT3. |
Gene id: | 10000 |
Gene name: | AKT3 |
Gene alias: | DKFZp434N0250|PKB-GAMMA|PKBG|PRKBG|RAC-PK-gamma|RAC-gamma|STK-2 |
Gene description: | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) |
Immunogen: | A synthetic peptide corresponding to human AKT3. |
Immunogen sequence/protein sequence: | CSPTSQIDNIGEEEM |
Protein accession: | NP_005456;NP_859029 |
Form: | Liquid |
Concentration: | 0.5 mg/mL |
Recommend dilutions: | ELISA (1:16000) Western Blot (1-3 ug/mL) The optimal working dilution should be determined by the end user. |
Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Product type: | Primary antibodies |
Host species: | Goat |
Antigen species / target species: | Human |
Specificity: | This antibody is expected to recognize an epitope corresponding to both isoforms of human AKT3 protein. This antibody does not cross-react with human AKT1/2. |
Reactivity: | Human,Mouse,Rat |
Application image: | ![]() |
Application image note: | AKT3 polyclonal antibody (Cat # PAB6709) (1 ug/mL) staining of HepG2 lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |
Applications: | ELISA,WB-Ce |
Shipping condition: | Dry Ice |
Publications: | AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon.Zinda MJ, Johnson MA, Paul JD, Horn C, Konicek BW, Lu ZH, Sandusky G, Thomas JE, Neubauer BL, Lai MT, Graff JR. Clin Cancer Res. 2001 Aug;7(8):2475-9. |